Epidermal Growth Factor Receptor—Negative Colorectal Cancer: Is There Truly Such an Entity?

This publication has 10 references indexed in Scilit:

• Epidermal growth factor.
  Published by Elsevier ,2021
• Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
  Journal of Clinical Oncology, 2005
• Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
  New England Journal of Medicine, 2004
• Immunohistochemical Detection of EGFR in Paraffin-embedded Tumor Tissues
  Journal of Histochemistry & Cytochemistry, 2004
• Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor
  Journal of Clinical Oncology, 2004
• The tethered configuration of the EGF receptor extracellular domain exerts only a limited control of receptor function
  Proceedings of the National Academy of Sciences, 2004
• A structure-based model for ligand binding and dimerization of EGF receptors
  Proceedings of the National Academy of Sciences, 2004
• The EGF receptor family as targets for cancer therapy
  Oncogene, 2000
• Oncoprotein stability after tumour resection
  British Journal of Cancer, 1990
• High-affinity epidermal growth factor binding is specifically reduced by a monoclonal antibody, and appears necessary for early responses.
  The Journal of cell biology, 1990